by reason for retraction – Page 30

Four papers by Athira CEO earn expressions of concern

Leen Kawas, President and CEO of Athira Pharma. (PRNewsfoto/Athira Pharma, Inc.)

A group of researchers at Washington State University has received four expressions of concern for papers whose findings underpin a publicly traded company founded by two of the most senior authors on the articles.

The studies, all of which appeared in the Journal of Pharmacology and Experimental Therapeutics, came from the labs of Joseph Harding, a medical chemist at Washington State, and his colleague Jay Wright. Published between 2011 and 2014, the four articles report on a molecule called angiotensin IV, work which Harding and Wright leveraged to spin-off Athira, a Seattle-based biotech firm developing treatments for conditions including Alzheimer’s and Parkinson’s disease.

The CEO of Athira, formerly known as M3 Biotechnology, is Leen Kawas, once a PhD student at Washington State whose 2011 doctoral dissertation provided figures for this fraught 2011 article in JPET, which earned a correction in 2014. Earlier this year, as STAT reported, Kawas was forced to take a leave of absence from the company over concerns that she altered images in several papers. And there has been other scrutiny of the company.

Alzheimer’s diagnosis paper retracted for failure to disclose conflicts of interest, other issues

A surgery journal has retracted a 2021 article by a group of researchers in Brazil for failure to disclose a key conflict of interest and other problems.

“Intracranial pressure waveform changes in Alzheimer’s disease and mild cognitive impairment” — which now seems to have disappeared entirely from the journal’s site — appeared in Surgical Neurology International in July. Led by Estela Barbosa Ribeiro, a nurse at the Federal University of São Carlos, in São Paulo, the article, still available and not marked retracted on PubMed Central, purported to find that measuring intracranial pressure:

“Fabulous document”, “very helpful guidance”: Sleuths react to recommendations for handling image integrity issues

Retraction Watch readers are likely familiar with the varied — and often unsatisfying — responses of journals to scientific sleuthing that uncovers potential problems with published images. Some editors take the issues seriously, even hiring staff to respond to allegations and vet manuscripts before publication. Some, however, take years to handle the allegations, or ignore them altogether.

Recently, STM’s Standards and Technology Committee (STEC) appointed a working group to look at these issues At a webinar last week, the group — including members from the American Chemical Society, Elsevier, Springer Nature, Taylor & Francis, Wiley, and other publishers — released a draft of their recommendations, which:

Highly cited paper marks 14th retraction for Chinese Academy of Sciences researcher

A chemistry journal has retracted a 2014 paper by a group from China after the first author on the article copped to having Photoshopped a figure — marking the second retraction for members of the group in less than a week and the 14th for one of the authors.

The paper, “Polymer nanodots of graphitic carbon nitride as effective fluorescent probes for the detection of Fe3+ and Cu2+ ions,” appeared in Nanoscale and was written by a group with ties to Soochow University, Hefei University of Technology and the Chinese Academy of Sciences, in Beijing, and Yale University. The first author was Shouwei Zhang, whose name appears on at least seven papers flagged on PubPeer for problematic images.

The senior author was Xiangke Wang, whose tally of PubPeer entries is now at 76 and who now has 14 retractions. One of those, the 2013 article “Superior adsorption capacity of hierarchical iron oxide@magnesium silicate magnetic nanorods for fast removal of organic pollutants from aqueous solution,” was retracted from the Journal of Materials Chemistry A on September 13, with the following notice:

Former Emory division director committed misconduct, says federal watchdog

A cancer researcher who was a former division director at Emory University in Atlanta “engaged in research misconduct by knowingly, intentionally, and/or recklessly falsifying data” in a federal grant application and six published papers, according to new findings from the U.S. Office of Research Integrity.

Ya Wang, who retired from Emory a year ago, “falsified protein immunoblot data by reusing and relabeling the same images to represent different experimental conditions in mammalian tissue culture models of DNA damage and repair in eighteen (18) figure panels in eleven (11) figures in one (1) grant application and six (6) published papers,” the ORI said.

Wang “neither admits nor denies” ORI’s findings of misconduct, according to the agency’s report on the case. She agreed to a four-year ban on any federal funding, and to correct or retract four papers:

Authors who don’t disclose conflicts of interest? “[W]e cannot force them to do so,” says editor

Nanshan Zhong, by 东方(美國之音記者) via Wikimedia

Do journal editors have the responsibility to ensure authors are disclosing relevant conflicts of interest?

According to the editor of one Elsevier journal, the answer is “no.”

The case marks the second time this year that the editor of an Elsevier journal has been less than dogged about enforcing the company’s clearly stated policies about undisclosed conflicts.

Publisher investigating all of an author’s papers following reporting by Retraction Watch

Less than two weeks after Retraction Watch reported that an abstract from 2019 included what appeared to be text from plagiarism detection software, the publisher has subjected the paper to an expression of concern and is investigating all of the lead author’s papers.

The paper,”Identification of Selective Forwarding Attacks in Remote locator Network utilizing Adaptive Trust Framework,” appeared as part of an IOP Conference Series. Nick Wise, an engineering graduate student at Cambridge, flagged the incident on Twitter, which IOP Publishing told us they had not yet heard about.

Today, IOP Publishing spokesperson Rachael Harper told Retraction Watch:

Obama intelligence official shortchanged grad student in 2015 book

A top intelligence official in the Obama administration failed to adequately credit a research assistant for a 2015 book but eventually relented after the grad student refused to back down about the slight, Retraction Watch has learned.

Gregory Treverton, who served as chairman of President Obama’s National Intelligence Council, wrote “National Intelligence and Science: Beyond the Great Divide in Analysis and Policy” with Wilhelm Agrell, a Swedish political scientist. At the time, Treverton was at the RAND Corporation, and he enlisted the help of Tyler Lippert, then a student at the Pardee RAND Graduate School and a RAND analyst.

According to Lippert, Treverton used extensive passages of text that Lippert provided to him with no acknowledgment that Lippert had done the work. Emails between Lippert and Treverton obtained by Retraction Watch show an increasingly acrimonious exchange between the two scholars.

University orders PhD supervisor to retract paper that plagiarized his student

A researcher at the University of Newcastle in Australia plagiarized a former student’s thesis, according to a summary of a university investigation obtained by Retraction Watch.

Andy Eamens, who at least until recently was an agronomy researcher at Newcastle, published a paper in 2019 that included work by Kate Hutcheon, whose PhD work he supervised, without any credit. Hutcheon, who earned her PhD in 2017, contacted the journal, Agronomy, an MDPI title, in November 2019.

The journal, Hutcheon told Retraction Watch, “forwarded a copy of my complaint directly to my PhD supervisor (without my consent). Thankfully they also forwarded me a copy of his response.” In what we found a bit confusing, to say the least, Eamens wrote, in part:

Introducing two sites that claim to sell authorships on scientific papers

Two years ago, we reported on a website based in Russia that claimed to have brokered authorships for more than 10,000 researchers. (Apparently, neither our coverage nor a cease-and-desist letter from Clarivate Analytics had any effect on the site’s operations.)

And now, we bring you news of what look like two very similar sites — one out of Iran, and one out of Latvia.

The site in Iran, Teziran.org, claims to offer a variety of services, from help with immigration issues to scientific training. What caught our eye in particular was a section of the site (pictured above) that lists a number of “articles ready for acceptance” — at least by Google Translate:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: